NDC 0019-1333

Optiray 350

Ioversol

Optiray 350 is a Intra-arterial; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Liebel-flarsheim Company Llc. The primary component is Ioversol.

Product ID0019-1333_0d687753-5c3f-47b3-921e-4c2f22ba6717
NDC0019-1333
Product TypeHuman Prescription Drug
Proprietary NameOptiray 350
Generic NameIoversol
Dosage FormInjection
Route of AdministrationINTRA-ARTERIAL; INTRAVENOUS
Marketing Start Date2012-03-04
Marketing CategoryNDA / NDA
Application NumberNDA019710
Labeler NameLiebel-Flarsheim Company LLC
Substance NameIOVERSOL
Active Ingredient Strength741 mg/mL
Pharm ClassesRadiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0019-1333-00

20 SYRINGE, PLASTIC in 1 CARTON (0019-1333-00) > 100 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2012-03-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0019-1333-90 [00019133390]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-00 [00019133300]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-75 [00019133375]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-55 [00019133355]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-03-04

NDC 0019-1333-21 [00019133321]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-77 [00019133377]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-91 [00019133391]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-16 [00019133316]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-41 [00019133341]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04
Marketing End Date2016-03-07

NDC 0019-1333-85 [00019133385]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-03-04

NDC 0019-1333-95 [00019133395]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-87 [00019133387]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-27 [00019133327]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-51 [00019133351]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA020923
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2011-10-17

NDC 0019-1333-06 [00019133306]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-83 [00019133383]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-81 [00019133381]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-11 [00019133311]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-61 [00019133361]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA020923
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2011-10-17

NDC 0019-1333-78 [00019133378]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1333-52 [00019133352]

Optiray 350 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

Drug Details

Active Ingredients

IngredientStrength
IOVERSOL741 mg/mL

OpenFDA Data

SPL SET ID:549d38db-d4ed-4708-8f76-7cdaa157063f
Manufacturer
UNII
UPC Code
  • 0300191323873
  • 0300191324870
  • 0300191332905
  • 0300191333872
  • Pharmacological Class

    • Radiographic Contrast Agent [EPC]
    • X-Ray Contrast Activity [MoA]

    NDC Crossover Matching brand name "Optiray 350" or generic name "Ioversol"

    NDCBrand NameGeneric Name
    0019-1323OptirayIoversol
    0019-1324OptirayIoversol
    0019-1332OptirayIoversol
    0019-1333OptirayIoversol

    Trademark Results [Optiray]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    OPTIRAY
    OPTIRAY
    73710159 1526467 Live/Registered
    MALLINCKRODT, INC.
    1988-02-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.